Last reviewed · How we verify
Pseudobulbar affect
Approved treatments
- Quinidine Gluconate · Eli Lilly
Quinidine Gluconate works by blocking the M2 muscarinic acetylcholine receptor, which helps regulate heart rhythm. - Delsym · Generic (originally Roche)
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pseudobulbar affect patent landscape — cliff calendar, originator estates, attackable patents
- Pseudobulbar affect treatment landscape brief
- Pseudobulbar affect treatment updates RSS
Frequently asked questions about Pseudobulbar affect
What drugs treat Pseudobulbar affect?
Tracked treatments include Quinidine Gluconate, Delsym.
What is the treatment for Pseudobulbar affect?
Standard treatment for Pseudobulbar affect includes Quinidine Gluconate, Delsym. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pseudobulbar affect patent cliff · Pseudobulbar affect CI report
- Treatment: Quinidine Gluconate · Eli Lilly
- Treatment: Delsym · Generic (originally Roche)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing